Animol Discovery

Boston, United States

Animol Discovery is a biopharmaceutical company focused on identifying and developing next- generation antiparasitics and therapeutics.

$12.0M raised

Oct 2025

Series C

Biopharma Biotechnology Wellness

Top Investors

Novalis LifeSciences Anterra Capital Finistere Ventures Endeavor8

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Animol Discovery

How much funding has Animol Discovery raised?

Animol Discovery has raised $12.0M in total funding. The most recent round was Series C. The last funding was announced in October 2025.

Who are Animol Discovery's investors?

Animol Discovery's investors include Novalis LifeSciences, Anterra Capital, Finistere Ventures, Endeavor8.

Where is Animol Discovery headquartered?

Animol Discovery is headquartered in Boston, United States.

What does Animol Discovery do?

Animol Discovery is a biopharmaceutical company focused on identifying and developing next- generation antiparasitics and therapeutics.

What stage is Animol Discovery at?

Animol Discovery is at the Series C stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 17, 2025.

MLA

"Animol Discovery — Funding & Investors." VCBacked, October 17, 2025, https://www.vcbacked.co/company/animol-discovery. Accessed July 5, 2026.

APA

VCBacked. (2025). Animol Discovery — Funding & Investors. Retrieved July 5, 2026, from https://www.vcbacked.co/company/animol-discovery

Wikipedia (cite web)

{{cite web |title=Animol Discovery — Funding & Investors |url=https://www.vcbacked.co/company/animol-discovery |website=VCBacked |access-date=July 5, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 17, 2025.

Similar Companies in Biopharma

View all

Allterum Therapeutics

Living In Silico Inc.